Related Experiment Video
Updated: May 28, 2026

09:02
Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
IgA Subclasses and Free Light Chains in Celiac Disease: A Pilot Study
Valeria Carnazzo1, Viviana Grieco2, Valerio Basile3
1Department of Clinical Pathology, Santa Maria Goretti Hospital, 04100 Latina, Italy.
International Journal of Molecular Sciences
|May 27, 2026
Summary
Celiac disease (CD) involves altered IgA subclasses and free light chains (FLCs). Newly diagnosed patients show increased IgA1 and preferential lambda light chain use, indicating immune response reorganization.
Area of Science:
- Immunology
- Gastroenterology
Background:
- Celiac disease (CD) is an autoimmune enteropathy triggered by gliadin in genetically susceptible individuals.
- The immune response in CD is characterized by IgA-driven inflammation, but IgA subclasses (IgA1, IgA2) and free light chains (FLCs) roles are unclear.
Purpose of the Study:
- To characterize IgA subclasses and FLC profiles in newly diagnosed celiac patients.
- To explore potential biomarkers for immune dysregulation in CD.
Main Methods:
- Sera from 108 CD patients and 29 controls were analyzed.
- Assessed conventional serological markers, total IgA, IgA1, IgA2, and FLCs using turbidimetric methods.
Main Results:
- CD patients showed higher total IgA and an increased IgA1/IgA2 ratio.
- A decreased kappa/lambda (k/λ) ratio was observed in CD patients.
- Combined biomarkers yielded an AUC of 0.827, indicating complementary diagnostic information.
Conclusions:
- Findings suggest a reorganization of the IgA compartment in CD, with IgA1 expansion and preferential lambda light chain usage.
- These alterations highlight coordinated changes in the humoral immune response in celiac disease.
- Further validation in larger cohorts is needed; these markers may refine CD characterization.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
